Who’s who in the iPS cell field? In this post, I examine the people, journals, places, funding agencies, and companies that are the leaders in the iPS cell field. I start with publishing. Last year we did a post on publishing trends in the iPS cell field. It suggested that the iPS cell field was exploding […]
Who’s who in iPS cells: scientists, journals, funding agencies, countries, and biotechs Read More »
For many of us in the biomedical research field, we have always wanted to be a professor and run our own research lab even if it meant the gauntlet of the dreaded academic job search. For some it is fair to say that that goal is really a passion, a dream. However, to achieve
Advice for the academic job search Read More »
The tragic 9.0 earthquake and tsunamis that hit Japan a few weeks ago are having lasting consequences not only for Japan, but also for the world via radiation. One area of particular concern is the radiation that has leaked and is continuing to leak from the damaged nuclear reactors. At this point, the radiation
A reality check on the radiation spreading across the globe Read More »
It was only six months ago that the stem cell field was aflutter over the report by the Rossi group that they could reprogram iPS cells with an astonishingly high efficiency using just RNAs. This completely non-genetic, high efficiency approach seemed like a revolution for the iPS cell field. It also seemed like what we
Is RNA-based iPS cell production a flash in the pan/tissue culture dish? Read More »
A growing body of evidence has convincingly argued that iPS cells contain numerous abnormalities at the genetic and epigenetic levels. Often these changes have links to the machinery in cells that is responsible for cancer. As a result, many in the stem cell field have raised the notion that iPS cells may never be able
New papers support growing serious safety concerns about iPS cells Read More »
Part of the Republican’s so-called “Pledge to America” was to cut $100 billion from the federal budget. Even though fiscal year 2011 is already almost half over, Republicans driven by Tea Party Mad Hatters have proposed to cut $100 billion from the budget for this year, increasing their proposed cuts of many programs including deeper
The Republican “Sledge to America” Read More »
Everyone has been understandably stressed about how the ongoing federal legislative process might effect funding for research including stem cell research. Particularly worrisome was the proposal from the new Republican-controlled House of Representatives to cut $100 billion from the budget. Today brought news (reported at one of my favorite blogs, The Great Beyond) that in
Great news: Initial GOP list of proposed cuts mostly spares NIH! Read More »
It’s been more than 4 years since Shinya Yamanaka published the remarkable finding that his lab could transform or “reprogram” regular cells called fibroblasts into a very unique state that was quite similar to that of embryonic stem cells (ESC). Yamanaka called these new cells “iPS cells” for induced pluripotent stem cells. Since that time,
The Inside Scoop on iPS cells early in 2011 Read More »
Reportedly, House Republicans are proposing a continuing resolution (CR) to fund the rest of FY2011 at 2008 funding levels. To achieve such an end, the Republicans would have to invoke serious cuts through the federal budget. Not only would such cuts likely damage the U.S. economy, but also they would have major other negative consequences.
Science is a national security issue Read More »
A new paper is out from a team at The Salk lead by Joseph Ecker that the methylomes of many different human iPS cells. Their conclusion is that while iPS cells and ES cells are generally very similar in terms of the global portions of the genomes that are methylated, iPS cells exhibited hundreds of
iPS cells are not going to replace ES cells Read More »